arrow Log In to View Account     |      
HOME
Johns Hopkins Medicine
Hopkins Logo


Patient with Diabetic Macular Edema - Case 2

  Presented by the Johns Hopkins University School of Medicine


 

Neil M. Bressler, MD

OVERVIEW

The retina community is experiencing an influx of information for the management and treatment of patients with retinal vein occlusions (RVO) and diabetic macular edema (DME). This assortment of data mainly comes from clinical trials which are designed to test and assess various treatments, offer dosing recommendations, and combinations thereof for different patient populations. There will be opportunities to analyze and discuss the new data especially as it relates to daily clinical practice and clinical decision-making. This activity features an interactive case study that focuses on the practical application of new treatments for patients with RVO and DME.

GOAL

The goal of this educational activity is to help retina specialists meet individual patients’ needs based on each patient’s unique risk/benefit profile for optimal visual outcomes.

TARGET AUDIENCE

This activity is designed for retina specialists in attendance at the American Society of Retina Specialists 28th Annual Meeting. No prerequisites required.

LEARNING OBJECTIVES

After completing this activity, the participant will demonstrate the ability to:

  • EVALUATE the results of the latest clinical trials for the management of patients with DME.
  • ASSESS the results of the latest clinical trials for the management of patients with RVO.
  • APPLY results from the latest clinical trials in RVO and DME in clinical case scenarios.

The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

ACCREDITATION STATEMENT

The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENTS

The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The estimated time to complete this activity: 30 minutes.

Release date: April 11, 2011. Expiration date: April 11, 2013.

HOW TO RECEIVE CREDIT OR CONTACT HOURS

The following interactive case activity consists of 3 sections: a pre-test, an interactive case with decision points, and a CME post-test with an evaluation. All 3 sections must be completed to receive CME credit. A certificate of participation will be available online immediately following successful completion of the module.

FULL DISCLOSURE POLICY AFFECTING CME ACTIVITIES

As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) to require a signed disclosure of the existence of financial relationships with industry from any individual in a position to control the content of a CME activity sponsored by OCME. Members of the Planning Committee are required to disclose all relationships regardless of their relevance to the content of the activity. Speakers are required to disclose only those relationships that are relevant to their specific presentation. The following relationships have been reported for this activity:

Author
Neil M. Bressler, MD (Chair)
The James P. Gills Professor of Ophthalmology
Chief, Retina Division
Wilmer Eye Institute
Johns Hopkins University School of Medicine
Baltimore, Maryland
Reports receiving grants/research support from Abbott Medical Optics, Allergan, Inc, Bausch & Lomb Incorporated, Carl Zeiss Meditec, The EMMES Corporation, ForSight Labs, LLC, Genentech, Inc, Genzyme Corporation, Lumenis, NotalVision, Novartis, Ora, Inc, QLT Inc, Regeneron Pharmaceuticals, Inc, and Steba Biotech.

Planners
Neil M. Bressler, MD (Chair)
Reports receiving grants/research support and serving as a Principal Investigator for Abbott Medical Optics, Allergan, Inc, Bausch & Lomb Incorporated, Carl Zeiss Meditec, The EMMES Corporation, ForSight Labs, LLC, Genzyme Corporation, Lumenis, Ora, Inc, QLT Inc, Regeneron Pharmaceuticals, Inc, Steba Biotech; and receiving grants/research support and serving as co-investigator for Genentech, Inc, NotalVision, and Novartis. Dr Bressler also reports that his spouse, Susan B. Bressler, MD, reports serving as a Principal Investigator for Notal Vision, as a co-investigator for Genentech, Inc, and Novartis, and as a consultant for GlaxoSmithKline.

Susan B. Bressler, MD
Reports serving as a Principal Investigator for Notal Vision, as a co-investigator for Genentech, Inc, and Novartis, and as a consultant for GlaxoSmithKline. Dr Bressler also reports that her spouse, Neil M. Bressler, MD, reports receiving grants/research support and serving as a Principal Investigator for Abbott Medical Optics, Allergan, Inc, Bausch & Lomb Incorporated, Carl Zeiss Meditec, The EMMES Corporation, ForSight Labs, LLC, Genzyme Corporation, Lumenis, Ora, Inc, QLT Inc, Regeneron Pharmaceuticals, Inc, Steba Biotech; and receiving grants/research support and serving as co-investigator for Genentech, Inc, NotalVision, and Novartis.

No other planners have indicated that they have any financial interests or relationships with a commercial entity.

Note: Grants to investigators at the Johns Hopkins University are negotiated and administered by the institution that receives the grant, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).

OFF-LABEL PRODUCT DISCUSSION

The following faculty member has disclosed that their presentation will reference unlabeled/unapproved use of drugs or products:

Dr Neil M. Bressler–bevacizumab, ranibizumab, and triamcinolone.

DISCLAIMER

The opinions and recommendations expressed by faculty and other experts whose input is included in this activity are their own. This enduring material is produced for educational purposes only. Use of the Johns Hopkins University School of Medicine name implies review of educational format, design, and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.

INTERNET CME POLICY

The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protect the privacy of its members and customers. Johns Hopkins University School of Medicine CME maintains its Internet site as an information resource and service for physicians, other health professionals, and the public. Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based activity. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine’s CME activity. CME collects only the information necessary to provide you with the services that you request.


CONFIDENTIALITY DISCLAIMER FOR CME ACTIVITY PARTICIPANT

I certify that I am participating in this Johns Hopkins University School of Medicine activity for CME-accredited training and/or educational purposes.

I understand that while I am participating in this capacity, I may be exposed to "protected health information," as that term is defined and used in Johns Hopkins policies and in the federal HIPAA privacy regulations (the "Privacy Regulations"). Protected health information is information about a person’s health or treatment that identifies the person. I also understand that while I am participating in this capacity I will be treated as a temporary member of Johns Hopkins for purposes of the Privacy Regulations only.

I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential.

I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is: Johns Hopkins Privacy Officer, telephone: 410-502-7983, e-mail: HIPAA@jhmi.edu.

“The Office of Continuing Medical Education at the Johns Hopkins University School of Medicine, as sponsor of this activity, has relayed information with the CME attendees/participants and certify that the visitor is here for training, education and/or observation purposes only.”

Johns Hopkins University School of Medicine
Office of Continuing Medical Education
720 Rutland Avenue/Turner 20
Baltimore, Maryland 21205-2195
Reviewed & Approved by: General Counsel, Johns Hopkins Medicine (4/1/09)

HARDWARE & SOFTWARE REQUIREMENTS

Pentium 800 processor or greater, Windows 98/NT/200/XP or Mac OS 9/X or later, Microsoft Internet Explorer, Safari, Firefox, Windows Media Player 9.0 or later Flash player, 128 MB of RAM Monitor settings: High color at 800 x 600 pixels, Sound card and speakers, Adobe Acrobat Reader.

Instructions
The following is an interactive educational case module designed to help you gauge your basic knowledge of the topic and then direct you to areas you may need to focus on. It consists of 3 sections: an unaccredited pre-test, an interactive case study, and a CME post-test. All 3 sections must be completed to receive CME credit.

Supported by an educational grant from Genentech, Inc.

procced to pretest
footer